PMDA
- Application: Xospata
- Local brand name: Xospata
- Status: approved
🇯🇵 Gilteritinib Exposure in Japan
Gilteritinib Exposure (Gilteritinib Exposure) regulatory status in Japan.
Marketing authorisation
Gilteritinib Exposure in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Gilteritinib Exposure approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for Gilteritinib Exposure in Japan?
Astellas Pharma Korea, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.